Cimicoxib
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB05095 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 28 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | headache disorder | KG + DL |
| 2 | trigeminal autonomic cephalalgia | KG + DL |
| 3 | tendinitis | KG + DL |
| 4 | rheumatoid arthritis | KG + DL |
| 5 | idiopathic granulomatous myositis | KG + DL |
| 6 | myositis fibrosa | KG + DL |
| 7 | common cold | KG + DL |
| 8 | Glanzmann thrombasthenia | KG + DL |
| 9 | fibromyalgia | KG + DL |
| 10 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 11 | primary release disorder of platelets | KG + DL |
| 12 | inclusion body myositis | KG + DL |
| 13 | brachydactyly-syndactyly syndrome | KG + DL |
| 14 | osteoarthritis susceptibility | KG + DL |
| 15 | pseudo-von Willebrand disease | KG + DL |
| 16 | gout | KG + DL |
| 17 | congenital hypotrichosis milia | KG + DL |
| 18 | hypotrichosis simplex of the scalp | KG + DL |
| 19 | filariasis | KG + DL |
| 20 | hemorrhagic disorder due to a constitutional thrombocytopenia | KG + DL |
| 21 | bleeding diathesis due to a collagen receptor defect | KG + DL |
| 22 | exostosis | KG + DL |
| 23 | diffuse alopecia areata | KG + DL |
| 24 | congenital prothrombin deficiency | KG + DL |
| 25 | thrombotic disease | KG + DL |
| 26 | alopecia | KG + DL |
| 27 | Scott syndrome | KG + DL |
| 28 | thromboangiitis obliterans | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.